• All Courts
  • Federal Courts
  • Bankruptcies
  • PTAB
  • ITC
Track Search
Export
Download All
Active Filters1
3,411 results

Shionogi & Co., Ltd. et al v. Norwich Pharmaceuticals, Inc. et al

Docket 1:24-cv-01264, Delaware District Court (Nov. 18, 2024)
Judge Maryellen Noreika, presiding
Patent - Abbreviated New Drug Application (ANDA)
DivisionWilmington
FlagsANDA, PATENT
Cause35:271 Patent Infringement
Case Type835 Patent - Abbreviated New Drug Application (ANDA)
Tags835 Patent, Abbreviated New Drug Application, Anda, 835 Patent, Abbreviated New Drug Application, Anda
Plaintiff Shionogi & Co., Ltd.
Plaintiff Hoffmann-La Roche Inc.
Plaintiff Genentech, Inc.
...
cite Cite Docket
Analyze

Samsara Inc. v. Motive Technologies Inc.

Docket 3:24-cv-06049, California Northern District Court (Aug. 27, 2024)
Judge James Donato, presiding
Patent
DivisionSan Francisco
FlagsADRMOP, RELATE
Cause28:1338 Patent Infringement
Case Type830 Patent
Tags830 Patent, 830 Patent
Patent11127130; 11190373; 11611621, 11127130, 11190373, 11611621
Plaintiff Samsara Inc.
Defendant Motive Technologies Inc.
cite Cite Docket
Analyze

Samsara Inc. v. Motive Technologies Inc.

Docket 4:24-cv-06049, California Northern District Court (Aug. 27, 2024)
Judge James Donato, presiding
Patent
DivisionOakland
FlagsADRMOP, RELATE
Cause28:1338 Patent Infringement
Case Type830 Patent
Tags830 Patent, 830 Patent
Plaintiff Samsara Inc.
Defendant Motive Technologies Inc.
cite Cite Docket
Analyze

Amicus Therapeutics US, LLC et al v. Teva Pharmaceuticals USA, Inc. et al

Docket 1:24-cv-00696, Delaware District Court (June 13, 2024)
Judge Christopher J. Burke, presiding
Patent - Abbreviated New Drug Application (ANDA)
DivisionWilmington
FlagsCLOSED, ANDA, PATENT
Cause35:271 Patent Infringement
Case Type835 Patent - Abbreviated New Drug Application (ANDA)
Tags835 Patent, Abbreviated New Drug Application, Anda, 835 Patent, Abbreviated New Drug Application, Anda
DeadlineDate of Expiration of Patent: 1/11/2042.Thirty Month Stay Deadline: 2/10/2026.
Plaintiff Amicus Therapeutics US, LLC
Plaintiff Amicus Therapeutics, Inc.
Defendant Teva Pharmaceuticals USA, Inc.
...
cite Cite Docket
Analyze

Technoprobe S.p.A. v. FormFactor, Inc.

Docket 1:24-cv-00650, Delaware District Court (May 31, 2024)
Judge Jennifer Choe-Groves, presiding
Patent
DivisionWilmington
FlagsPATENT
Cause35:271 Patent Infringement
Case Type830 Patent
Tags830 Patent, 830 Patent
Plaintiff Technoprobe S.p.A.
Defendant FormFactor, Inc.
Counter Claimant FormFactor, Inc.
...
cite Cite Docket
Analyze

Pfizer Inc. et al v. Teva Pharmaceuticals, Inc. et al

Docket 1:24-cv-00627, Delaware District Court (May 23, 2024)
Judge Colm F. Connolly, presiding
Patent - Abbreviated New Drug Application (ANDA)
DivisionWilmington
FlagsANDA, PATENT
Cause35:271 Patent Infringement
Case Type835 Patent - Abbreviated New Drug Application (ANDA)
Tags835 Patent, Abbreviated New Drug Application, Anda, 835 Patent, Abbreviated New Drug Application, Anda
DeadlineJoint Claim Construction Brief due by 9/5/2025.
DeadlineJoinder of Parties due by 9/26/2025., Amended Pleadings due by 9/26/2025.
Plaintiff Pfizer Inc.
Plaintiff Pfizer Ireland Pharmaceuticals
Defendant Teva Pharmaceuticals, Inc.
...
cite Cite Docket
Analyze

Pfizer Inc. et al v. Apotex, Inc. et al

Docket 1:24-cv-00621, Delaware District Court (May 23, 2024)
Judge Colm F. Connolly, presiding
Patent - Abbreviated New Drug Application (ANDA)
DivisionWilmington
FlagsANDA, LEAD, PATENT
Cause35:271 Patent Infringement
Case Type835 Patent - Abbreviated New Drug Application (ANDA)
Tags835 Patent, Abbreviated New Drug Application, Anda, 835 Patent, Abbreviated New Drug Application, Anda
DeadlineOn or before May 2, 2025, the parties shall exchange a list of those claim term(s)/phrase(s) that they believe need construction.
DeadlineThe Honorable Colm ? Connolly Chief, United States District Court Judge 25 16 Case 1:24-cv-00626-CFC Document 21 Filed 09/30/24 Page 26 of 27 PageID #: 159 EXHIBIT A Stay Deadline August 27, 2027 Rule 26(a)(1) Disclosures and Delaware Default Standard for Discovery Paragraph 3 Disclosures Plaintiffs’ Preliminary Disclosure of Asserted Claims and Accompanying Document Production Parties Submit Proposed Protective Order Parties Submit Proposed ESI Order Defendants’ Noninfringement Contentions and Accompanying Document Production Defendants’ Invalidity Contentions and Preliminary Disclosure of Asserted Art and Accompanying DocumentProduction Plaintiffs’ Infringement Contentions and Accompanying Document Production Parties Exchange Proposed Claim Termsto be Construed Parties Exchange Proposed Constructions and Supporting Intrinsic Evidence Parties Exchange Proposed Rebuttal Evidence Brief Served Parties File Joint Claim Construction Chart som Opening Claim Construction Brief Defendants’ Answering Claim Constructi, On or before May 27, 2025,the parties shall exchange any rebuttal intrinsic evidence fortheir proposed claims construction(s) of those claim term(s)/phrase(s).
Plaintiff Pfizer Inc.
Plaintiff Pfizer Ireland Pharmaceutials
Plaintiff Bristol-Myers Squibb Company
...
cite Cite Docket
Analyze

Samsung Electronics Co., Ltd. et al v. Netlist, Inc.

Docket 1:24-cv-00614, Delaware District Court (May 22, 2024)
Judge Jennifer L. Hall, presiding
Patent
DivisionWilmington
FlagsPATENT
Cause35:1 Patent Infringement
Case Type830 Patent
Tags830 Patent, 830 Patent
Plaintiff Samsung Electronics Co., Ltd.
Plaintiff Samsung Semiconductor, Inc.
Plaintiff Samsung Electronics America, Inc.
...
cite Cite Docket
Analyze
1 2 3 4 5 ... >>